Stephanie J. Ellison-Zelski, Ph.D. - Publications
Affiliations: | 2010 | University of Wisconsin, Madison, Madison, WI |
Area:
Molecular Biology, Cell Biology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Rajbhandari P, Schalper KA, Solodin NM, Ellison-Zelski SJ, Ping Lu K, Rimm DL, Alarid ET. Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation. Oncogene. 33: 1438-47. PMID 23542176 DOI: 10.1038/Onc.2013.78 | 0.687 | |||
2012 | Rajbhandari P, Finn G, Solodin NM, Singarapu KK, Sahu SC, Markley JL, Kadunc KJ, Ellison-Zelski SJ, Kariagina A, Haslam SZ, Lu KP, Alarid ET. Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1. Molecular and Cellular Biology. 32: 445-57. PMID 22064478 DOI: 10.1128/Mcb.06073-11 | 0.684 | |||
2010 | Ellison-Zelski SJ, Alarid ET. Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor. Molecular Cancer. 9: 263. PMID 20920219 DOI: 10.1186/1476-4598-9-263 | 0.735 | |||
2010 | Powers GL, Ellison-Zelski SJ, Casa AJ, Lee AV, Alarid ET. Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer. Oncogene. 29: 1509-18. PMID 19946334 DOI: 10.1038/Onc.2009.434 | 0.667 | |||
2009 | Ellison-Zelski SJ, Solodin NM, Alarid ET. Repression of ESR1 through actions of estrogen receptor alpha and Sin3A at the proximal promoter. Molecular and Cellular Biology. 29: 4949-58. PMID 19620290 DOI: 10.1128/Mcb.00383-09 | 0.697 | |||
2009 | Regehr KJ, Domenech M, Koepsel JT, Carver KC, Ellison-Zelski SJ, Murphy WL, Schuler LA, Alarid ET, Beebe DJ. Biological implications of polydimethylsiloxane-based microfluidic cell culture. Lab On a Chip. 9: 2132-9. PMID 19606288 DOI: 10.1039/B903043C | 0.589 | |||
Show low-probability matches. |